• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用乘客突变来估计驱动突变的时间,并识别突变体改变。

Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.

机构信息

Biometric Research Branch, National Cancer Institute, Bethesda, Maryland, USA.

出版信息

BMC Bioinformatics. 2013 Dec 13;14:363. doi: 10.1186/1471-2105-14-363.

DOI:10.1186/1471-2105-14-363
PMID:24330428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3903072/
Abstract

BACKGROUND

Recent developments in high-throughput genomic technologies make it possible to have a comprehensive view of genomic alterations in tumors on a whole genome scale. Only a small number of somatic alterations detected in tumor genomes are driver alterations which drive tumorigenesis. Most of the somatic alterations are passengers that are neutral to tumor cell selection. Although most research efforts are focused on analyzing driver alterations, the passenger alterations also provide valuable information about the history of tumor development.

RESULTS

In this paper, we develop a method for estimating the age of the tumor lineage and the timing of the driver alterations based on the number of passenger alterations. This method also identifies mutator genes which increase genomic instability when they are altered and provides estimates of the increased rate of alterations caused by each mutator gene. We applied this method to copy number data and DNA sequencing data for ovarian and lung tumors. We identified well known mutators such as TP53, PRKDC, BRCA1/2 as well as new mutator candidates PPP2R2A and the chromosomal region 22q13.33. We found that most mutator genes alter early during tumorigenesis and were able to estimate the age of individual tumor lineage in cell generations.

CONCLUSIONS

This is the first computational method to identify mutator genes and to take into account the increase of the alteration rate by mutator genes, providing more accurate estimates of the tumor age and the timing of driver alterations.

摘要

背景

高通量基因组技术的最新进展使得在全基因组范围内全面观察肿瘤中的基因组改变成为可能。在肿瘤基因组中检测到的少数体细胞改变是驱动肿瘤发生的驱动改变。大多数体细胞改变是对肿瘤细胞选择呈中性的乘客改变。尽管大多数研究都集中在分析驱动改变上,但乘客改变也为肿瘤发展的历史提供了有价值的信息。

结果

在本文中,我们开发了一种基于乘客改变数量来估计肿瘤谱系年龄和驱动改变时间的方法。该方法还识别了在改变时增加基因组不稳定性的突变基因,并提供了每个突变基因引起的改变率增加的估计。我们将该方法应用于卵巢和肺癌的拷贝数数据和 DNA 测序数据。我们确定了已知的突变基因,如 TP53、PRKDC、BRCA1/2,以及新的突变候选基因 PPP2R2A 和染色体区域 22q13.33。我们发现大多数突变基因在肿瘤发生的早期就发生了改变,并能够估计单个肿瘤谱系的细胞世代年龄。

结论

这是第一个识别突变基因并考虑突变基因改变率增加的计算方法,它提供了更准确的肿瘤年龄和驱动改变时间的估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/698df4ab10e4/1471-2105-14-363-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/df22d75cbdb3/1471-2105-14-363-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/3d7a1b6cd674/1471-2105-14-363-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/15aa4f3f0cd6/1471-2105-14-363-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/698df4ab10e4/1471-2105-14-363-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/df22d75cbdb3/1471-2105-14-363-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/3d7a1b6cd674/1471-2105-14-363-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/15aa4f3f0cd6/1471-2105-14-363-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2154/3903072/698df4ab10e4/1471-2105-14-363-4.jpg

相似文献

1
Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.利用乘客突变来估计驱动突变的时间,并识别突变体改变。
BMC Bioinformatics. 2013 Dec 13;14:363. doi: 10.1186/1471-2105-14-363.
2
Identification of constrained cancer driver genes based on mutation timing.基于突变时间识别受限癌症驱动基因。
PLoS Comput Biol. 2015 Jan 8;11(1):e1004027. doi: 10.1371/journal.pcbi.1004027. eCollection 2015 Jan.
3
Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.利用正选择和负选择信号区分癌症基因和乘客基因。
Elife. 2021 Jan 11;10:e59629. doi: 10.7554/eLife.59629.
4
DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.DrGaP:一种在癌症测序研究中识别驱动基因和途径的强大工具。
Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003. Epub 2013 Aug 15.
5
Do mutator mutations fuel tumorigenesis?诱变突变会促进肿瘤发生吗?
Cancer Metastasis Rev. 2013 Dec;32(3-4):353-61. doi: 10.1007/s10555-013-9426-8.
6
Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.体细胞突变的癌症特异性高通量注释:驱动错义突变的计算预测
Cancer Res. 2009 Aug 15;69(16):6660-7. doi: 10.1158/0008-5472.CAN-09-1133. Epub 2009 Aug 4.
7
Prediction of cancer driver mutations in protein kinases.蛋白激酶中癌症驱动突变的预测
Cancer Res. 2008 Mar 15;68(6):1675-82. doi: 10.1158/0008-5472.CAN-07-5283.
8
[Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].[肺癌分子检测,下一代测序和循环肿瘤DNA发挥什么作用]
Ann Pathol. 2016 Jan;36(1):80-93. doi: 10.1016/j.annpat.2015.11.012. Epub 2016 Jan 20.
9
Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.从肿瘤基因组测序数据估算肿瘤发生过程中的突变顺序。
Bioinformatics. 2012 Jun 15;28(12):1555-61. doi: 10.1093/bioinformatics/bts168. Epub 2012 Apr 6.
10
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.由 APOBEC3A 和中尺度基因组特征驱动的癌症中的乘客热点突变。
Science. 2019 Jun 28;364(6447). doi: 10.1126/science.aaw2872.

引用本文的文献

1
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells.B55α与Greatwall表达水平之间的平衡预示着癌细胞对Greatwall抑制的敏感性。
Nat Commun. 2025 Aug 27;16(1):8016. doi: 10.1038/s41467-025-62943-z.
2
Zearalenone exposure differentially affects the ovarian proteome in pre-pubertal gilts during thermal neutral and heat stress conditions.玉米赤霉烯酮暴露在热中性和热应激条件下对未成年小母猪的卵巢蛋白质组产生不同的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae115.
3
Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis.

本文引用的文献

1
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
2
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.自我更新组织的癌症中,有一半或更多的体细胞突变发生在肿瘤起始之前。
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):1999-2004. doi: 10.1073/pnas.1221068110. Epub 2013 Jan 23.
3
Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition.PPP2R2A 缺失抑制同源重组 DNA 修复,并预测肿瘤对 PARP 抑制的敏感性。
在肿瘤发生过程中,体细胞突变的成对和更高阶的上位效应。
Math Biosci. 2023 Dec;366:109091. doi: 10.1016/j.mbs.2023.109091. Epub 2023 Nov 22.
4
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU.VPA 通过 PPP2R2A-Chk1 信号轴介导细胞周期进程的双向调节,以响应 HU。
Cell Death Dis. 2023 Feb 13;14(2):114. doi: 10.1038/s41419-023-05649-8.
5
Rate volatility and asymmetric segregation diversify mutation burden in cells with mutator alleles.具有突变倾向等位基因的细胞中,突变负担的速率波动和非对称分离使突变多样化。
Commun Biol. 2021 Jan 4;4(1):21. doi: 10.1038/s42003-020-01544-6.
6
PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization.PPP2R2A前列腺癌单倍体不足与较差的预后以及对触发中心体不稳定的B55α/PP2A重构的高易感性相关。
Oncogenesis. 2019 Dec 10;8(12):72. doi: 10.1038/s41389-019-0180-9.
7
PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.PP2A 全酶、底物特异性驱动细胞功能及癌症失调。
Adv Cancer Res. 2019;144:55-93. doi: 10.1016/bs.acr.2019.03.009. Epub 2019 Apr 12.
8
The MiAge Calculator: a DNA methylation-based mitotic age calculator of human tissue types.MiAge 计算器:一种基于 DNA 甲基化的人类组织类型有丝分裂年龄计算器。
Epigenetics. 2018;13(2):192-206. doi: 10.1080/15592294.2017.1389361. Epub 2018 Feb 6.
9
Mutant TP53 disrupts age-related accumulation patterns of somatic mutations in multiple cancer types.突变型TP53破坏了多种癌症类型中与年龄相关的体细胞突变积累模式。
Cancer Genet. 2016 Sep;209(9):376-380. doi: 10.1016/j.cancergen.2016.07.001. Epub 2016 Jul 9.
10
Identification and analysis of driver missense mutations using rotation forest with feature selection.使用带特征选择的旋转森林算法识别和分析驱动型错义突变
Biomed Res Int. 2014;2014:905951. doi: 10.1155/2014/905951. Epub 2014 Aug 27.
Cancer Res. 2012 Dec 15;72(24):6414-24. doi: 10.1158/0008-5472.CAN-12-1667. Epub 2012 Oct 18.
4
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).22q13.3缺失综合征(费兰-麦克德米德综合征)
Mol Syndromol. 2012 Apr;2(3-5):186-201. doi: 10.1159/000334260. Epub 2011 Nov 22.
5
Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.从肿瘤基因组测序数据估算肿瘤发生过程中的突变顺序。
Bioinformatics. 2012 Jun 15;28(12):1555-61. doi: 10.1093/bioinformatics/bts168. Epub 2012 Apr 6.
6
'Omic approaches to preventing or managing metastatic breast cancer.“针对预防或治疗转移性乳腺癌的奥米克戎方法。”
Breast Cancer Res. 2011;13(6):230. doi: 10.1186/bcr2923. Epub 2011 Dec 8.
7
The temporal order of genetic and pathway alterations in tumorigenesis.肿瘤发生中遗传和通路改变的时间顺序。
PLoS One. 2011;6(11):e27136. doi: 10.1371/journal.pone.0027136. Epub 2011 Nov 1.
8
Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.转移性皮肤鳞状细胞癌中蛋白酪氨酸磷酸酶受体 D 基因频繁缺失。
Int J Cancer. 2012 Aug 1;131(3):E216-26. doi: 10.1002/ijc.27333. Epub 2011 Dec 21.
9
Temporal dissection of tumorigenesis in primary cancers.原发性癌症中肿瘤发生的时程剖析。
Cancer Discov. 2011 Jul;1(2):137-43. doi: 10.1158/2159-8290.CD-11-0028. Epub 2011 Jun 29.
10
Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study.PPP2R2A作为前列腺癌易感基因的评估:一项全面的种系和体细胞研究。
Cancer Genet. 2011 Jul;204(7):375-81. doi: 10.1016/j.cancergen.2011.05.002.